Joline S.W. Lind
- Pulmonary and Respiratory Medicine top 10%
- Oncology top 10%
- Molecular Biology
- Endocrinology, Diabetes and Metabolism top 10%
- Radiology, Nuclear Medicine and Imaging
- Co-authors
- Egbert F. SmitSuresh SenanPieter E. PostmusFrank J. LagerwaardAnne‐Marie C. DingemansJan G. ZijlstraJaap E. TullekenGodefridus J. Peters
- Topics
- Lung Cancer Treatments and Mutations (13 papers)Colorectal Cancer Treatments and Studies (5 papers)Lung Cancer Research Studies (4 papers)
- Partner nations
- NetherlandsUnited StatesItaly
In The Last Decade
Joline S.W. Lind
20 papers receiving 641 citations
Peers
Comparison fields: 5 of 76
- Pulmonary and Respiratory Medicine 315
- Oncology 276
- Molecular Biology 184
- Endocrinology, Diabetes and Metabolism 108
- Radiology, Nuclear Medicine and Imaging 86
Countries citing papers authored by Joline S.W. Lind
This map shows the geographic impact of Joline S.W. Lind's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joline S.W. Lind with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joline S.W. Lind more than expected).
Fields of papers citing papers by Joline S.W. Lind
This network shows the impact of papers produced by Joline S.W. Lind. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joline S.W. Lind. The network helps show where Joline S.W. Lind may publish in the future.
Co-authorship network of co-authors of Joline S.W. Lind
This figure shows the co-authorship network connecting the top 25 collaborators of Joline S.W. Lind. A scholar is included among the top collaborators of Joline S.W. Lind based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joline S.W. Lind. Joline S.W. Lind is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 34 | |
| 3 | 25 | |
| 4 | 51 | |
| 5 | 18 | |
| 6 | 83 | |
| 7 | 15 | |
| 8 | 2 | |
| 9 | 68 | |
| 10 | 74 | |
| 11 | 20 | |
| 12 | 27 | |
| 13 | 18 | |
| 14 | 55 | |
| 15 | 9 | |
| 16 | 2 | |
| 17 | 21 | |
| 18 | [New therapies for the treatment of advanced non-small cell lung cancer: inhibitors of the epidermal growth factor receptor and angiogenesis]. | 2 |
| 19 | 1 | |
| 20 | 125 |
About Joline S.W. Lind
Joline S.W. Lind is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research, having authored 20 papers that have together received 656 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (13 papers), Colorectal Cancer Treatments and Studies (5 papers) and Lung Cancer Research Studies (4 papers). The work is most often cited by research in Oncology (276 citations), Pulmonary and Respiratory Medicine (315 citations) and Endocrinology, Diabetes and Metabolism (108 citations). Joline S.W. Lind has collaborated with scholars based in Netherlands, United States and Italy. Frequent co-authors include Egbert F. Smit, Suresh Senan, Pieter E. Postmus, Frank J. Lagerwaard, Anne‐Marie C. Dingemans, Jan G. Zijlstra, Jaap E. Tulleken, Godefridus J. Peters, Richard J. Honeywell and Elisa Giovannetti. Their work appears in journals such as Journal of Clinical Oncology, Cancer and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.